Palvella Therapeutics Inc/$PVLA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Palvella Therapeutics Inc
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
Ticker
$PVLA
Sector
Primary listing
Employees
29
Headquarters
Website
PVLA Metrics
BasicAdvanced
$1.9bn
-
-$3.71
-
-
Price and volume
Market cap
$1.9bn
52-week high
$151.18
52-week low
$20.20
Average daily volume
268k
Financial strength
Current ratio
5.2
Quick ratio
5.111
Long term debt to equity
65.007
Total debt to equity
65.729
Interest coverage (TTM)
-6.63%
Profitability
Management effectiveness
Return on assets (TTM)
-32.65%
Return on equity (TTM)
-92.10%
Valuation
Price to book
57.81
Price to tangible book (TTM)
57.81
Price to free cash flow (TTM)
-58.785
Free cash flow yield (TTM)
-1.70%
Free cash flow per share (TTM)
-2.223
Growth
Earnings per share change (TTM)
-52.66%
3-year earnings per share growth (CAGR)
-8.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Palvella Therapeutics Inc stock?
Palvella Therapeutics Inc (PVLA) has a market cap of $1.9B as of April 22, 2026.
What is the P/E ratio for Palvella Therapeutics Inc stock?
The price to earnings (P/E) ratio for Palvella Therapeutics Inc (PVLA) stock is 0 as of April 22, 2026.
Does Palvella Therapeutics Inc stock pay dividends?
No, Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders as of April 22, 2026.
When is the next Palvella Therapeutics Inc dividend payment date?
Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders.
What is the beta indicator for Palvella Therapeutics Inc?
Palvella Therapeutics Inc (PVLA) does not currently have a Beta indicator.